Skip to main content

Market Overview

Why Addex, Genetic Technologies And Obalon Are Moving Today

Share:
Why Addex, Genetic Technologies And Obalon Are Moving Today

Genetic Technologies (NASDAQ: GENE) shares are trading higher after the company provided an update on its COVID-19 severity risk test, saying predictive capabilities improved 100% over age and sex alone.

Genetic Technologies is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health.

Genetic Technologies shares were trading up 42.29% at $6.12 at the time of publication Thursday. The stock has a 52-week high of $10.30 and a 52-week low of $1.41.

Addex Therapeutics (NASDAQ: ADXN) shares are trading higher after the company announced it received an FDA IND approval to start a Phase 2A clinical study in its ADX71149 for Epilepsy.

Addex Therapeutics is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders.

Addex Therapeutics shares were trading up 29.09% at $13.62 at the time of publication. The stock has a 52-week high of $37.52 and a 52-week low of $6.19.

Obalon Therapeutics (NASDAQ: OBLN) shares are trading lower, reversing after the stock gained on Wednesday following news of a merger agreement with ReShape Lifesciences.

Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes Obalon Balloon System.

Obalon Therapeutics shares were trading down 31.52% at $5.67 at the time of publication. The stock has a 52-week high of $10.77 and a 52-week low of 62 cents.

 

Related Articles (GENE + ADXN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com